type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/19/2024 | 12/26/2024 | 1.17346000 |
| Dividends | 12/22/2023 | 12/27/2023 | 0.07106000 |
| Dividends | 12/20/2019 | 12/27/2019 | 0.01585000 |
| Dividends | 12/21/2018 | 12/27/2018 | 0.78406000 |
| Dividends | 12/22/2017 | 12/28/2017 | 0.57949000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| CRNX | Stock | Healthcare | US$ 9.01 B | 4,59% | |
Apogee Therapeutics, Inc. Common Stock
|
APGE | Stock | Healthcare | US$ 10.22 B | 4,29% |
CG Oncology, Inc. Common stock
|
CGON | Stock | Healthcare | US$ 6.62 B | 3,43% |
| TVTX | Stock | Healthcare | US$ 6.27 B | 3,13% | |
| DNTH | Stock | Healthcare | US$ 5.91 B | 2,99% | |
| XENE | Stock | Healthcare | US$ 5.85 B | 2,97% | |
Oruka Therapeutics, Inc.
|
ORKA | Stock | Healthcare | US$ 6.13 B | 2,84% |
| ACAD | Stock | Healthcare | US$ 4.83 B | 2,53% | |
| EWTX | Stock | Healthcare | US$ 4.56 B | 2,33% | |
|
Definium Therapeutics, Inc.
|
DFTX | Stock | Healthcare | US$ 5.11 B | 2,15% |
| DYN | Stock | Healthcare | US$ 4.53 B | 2,13% | |
|
Veradermics, Incorporated
|
MANE | Stock | Healthcare | US$ 4.08 B | 2,09% |
| RLAY | Stock | Healthcare | US$ 4.06 B | 2,06% | |
| AMLX | Stock | Healthcare | US$ 3.78 B | 1,93% | |
| DNLI | Stock | Healthcare | US$ 3.56 B | 1,89% | |
| IDYA | Stock | Healthcare | US$ 3.85 B | 1,80% | |
Structure Therapeutics Inc. American Depositary Shares
|
GPCR | Stock | Healthcare | US$ 3.38 B | 1,72% |
| TARS | Stock | Healthcare | US$ 3.65 B | 1,63% | |
| CLDX | Stock | Healthcare | US$ 3.12 B | 1,58% | |
| IMNM | Stock | Healthcare | US$ 3.08 B | 1,57% | |
|
Disc Medicine Inc.
|
IRON | Stock | Healthcare | US$ 3.04 B | 1,54% |
|
KINGHERO
|
KH6_old | Stock | Other | US$ 599.96 M | 1,49% |
|
MBX Biosciences, Inc. Common Stock
|
MBX | Stock | Healthcare | US$ 2.97 B | 1,49% |
| ZLAB | Stock | Healthcare | US$ 2.89 B | 1,41% | |
| VRDN | Stock | Healthcare | US$ 2.60 B | 1,30% | |
| BCRX | Stock | Healthcare | US$ 2.58 B | 1,29% | |
| SLS | Stock | Healthcare | US$ 2.80 B | 1,26% | |
| VERA | Stock | Healthcare | US$ 2.59 B | 1,26% | |
| NKTR | Stock | Healthcare | US$ 2.53 B | 1,24% | |
Rapport Therapeutics, Inc. Common Stock
|
RAPP | Stock | Healthcare | US$ 2.20 B | 1,19% |
| NUVB | Stock | Healthcare | US$ 2.38 B | 1,19% | |
Mineralys Therapeutics, Inc. Common Stock
|
MLYS | Stock | Healthcare | US$ 2.49 B | 1,16% |
| SRPT | Stock | Healthcare | US$ 2.43 B | 1,15% | |
Palvella Therapeutics, Inc
|
PVLA | Stock | Healthcare | US$ 2.24 B | 1,10% |
|
Kailera Therapeutics, Inc. Common Stock
|
KLRA | Stock | Healthcare | US$ 2.05 B | 1,09% |
| VCEL | Stock | Healthcare | US$ 2.07 B | 1,06% | |
| XNCR | Stock | Healthcare | US$ 1.98 B | 1,06% | |
| AGIO | Stock | Healthcare | US$ 1.98 B | 1,04% | |
|
Generate Biomedicines, Inc. Common Stock
|
GENB | Stock | Healthcare | US$ 2.10 B | 1,04% |
Zenas BioPharma, Inc. Common Stock
|
ZBIO | Stock | Healthcare | US$ 2.14 B | 1,03% |
| STOK | Stock | Healthcare | US$ 1.92 B | 0,99% | |
| IMCR | Stock | Healthcare | US$ 1.93 B | 0,96% | |
| GLPG | Stock | Healthcare | US$ 1.55 B | 0,95% | |
| CMPS | Stock | Healthcare | US$ 1.85 B | 0,92% | |
| TSHA | Stock | Healthcare | US$ 1.81 B | 0,84% | |
Bicara Therapeutics Inc. Common Stock
|
BCAX | Stock | Healthcare | US$ 1.53 B | 0,79% |
|
TYRA
|
TYRA_old | Stock | Healthcare | US$ 903.02 M | 0,77% |
Maze Therapeutics, Inc. Common Stock
|
MAZE | Stock | Healthcare | US$ 1.46 B | 0,75% |
ArriVent BioPharma, Inc. Common Stock
|
AVBP | Stock | Healthcare | US$ 1.53 B | 0,72% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX | Stock | Healthcare | US$ 1.53 B | 0,70% |
Average Investor10 user rating
4.0
(0 people)
ALPS Medical Breakthroughs ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $230.30 million.
Over the past 12 months, ALPS Medical Breakthroughs ETF recorded a return of 71.04%, with its price trading between $36.32 and $70.79 during the same period.
The ETF is traded under the ticker SBIO.
The current price of SBIO is $62.12. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
SBIO is currently trading at $62.12, with a market capitalization of approximately $230.297.958,00. Over the past year, the ETF has delivered a 71.04% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in SBIO through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol SBIO, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, SBIO has returned -10.11%, and 71.04% over the past year.
If you were to purchase 100 shares of SBIO at the current price of $62.12, your total investment would be $6,212.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
